First hit on Autologous Stem Cell Transplantation in Mantle cell lymphoma
Guilherme Perini, Hematologist at Hospital Israelita Albert Einstein in São Paulo, shared a post on X:
“First hit on Autologous Stem Cell Transplantation in Mantle cell lymphoma
Authors: Timothy S. Fenske, Xin Victoria Wang, Brian G. Till, Kristie A. Blum, Matthew Lunning, Hillard M. Lazarus, Paul A.S. Fishkin, Lale Kostakoglu Shields, David W. Scott, Ann S. LaCasce, Patrick B. Johnston, Amanda F. Cashen, Leslie L. Popplewell, Robert M. Dean, Nausheen Ahmed, , Nirav N. Shah, Nina D. Wagner-Johnston, Boyu Hu, Bhagirathbhai R. Dholaria, Richard F. Little, Jonathan W. Friedberg, John P. Leonard, Brad S. Kahl.
As data from Grupo GELL has shown, less than 40 percent of eligible patients in LatAm go to ASCT in MCL.
ClonoSeq is waycheaper than ASCT, and could help, in $-restricted countries, select patients who really benefit from ASCT…
And that was not the biggest hit in ASCT for MCL…”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023